Tuesday, June 30, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Partners Group’s Insiders Have Spent $60 Million on Shares. The July 15 Update Will Tell Them If They Were Right

Kennethcix by Kennethcix
June 30, 2026
in Analysis, European Markets, Market Commentary
0
Partners Group Stock
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

The top brass at Partners Group has been sending an unmistakable signal. Since February, company insiders have snapped up nearly 60 million Swiss francs worth of their own stock, with 31 million francs of that coming in June alone. Co-founder Alfred Gantner also added to his stake. Yet the market has barely blinked. The shares have lost more than 34% this year, trading at €705.20 — just 2.6% above the 52-week low of €686.80 — and the relative strength index has plunged to 25.1, deep in oversold territory.

Why are insiders buying while everyone else is selling? The answer lies in a redemption crisis that has shaken confidence in the Swiss private-markets giant. In early June, Partners Group was forced to cap withdrawals from its flagship Evergreen fund, the Partners Group Global Value SICAV. That vehicle, which manages $8.6 billion, received redemption requests equal to 9.8% of its net asset value — nearly double the contractual quarterly limit of 5%. A related Delaware vehicle saw requests of about 6%. The management responded by paying out only 62% of the requests in May, a move that stunned retail investors who had been drawn to the promise of liquidity in private equity.

The damage has been swift. The Evergreen platform, which supplies nearly half of the group’s revenue, now faces a projected drag on net asset growth of one to two percentage points in the second half of 2026 and all of 2027. And that is before factoring in the assault from Grizzly Research, a US short-seller that claims the Evergreen funds are overvalued by as much as 40%. Partners Group has dismissed the allegations as baseless and filed a criminal complaint, but the stock has kept sliding.

Analysts have responded by slashing their forecasts. Jefferies has a hold rating with a target of 760 francs, Bank of America holds at 850 francs, and Octavian remains a buyer at 1,175 francs. Oddo BHF downgraded to hold. The consensus is cautious, but the insider buying suggests management believes the sell-off is overdone.

Should investors sell immediately? Or is it worth buying Partners Group?

The key to understanding Partners Group’s predicament lies in the split nature of its client base. Institutional investors represent more than 80% of customers and generated over 80% of first-quarter inflows. These are sophisticated players who view liquidity restrictions as a structural feature of private markets, not a red flag. They are unlikely to panic. Retail investors, however, are a different story. For them, a redemption cap is a psychological blow that may accelerate withdrawals once the limits are lifted.

The bull case rests on that institutional stickiness. Partners Group reaffirmed its 2026 gross new money guidance of $26 billion to $32 billion and expects net inflows into Evergreen funds to stay positive for the first half. A broader recovery in private-equity exits could also help. The bear case warns that once trust erodes, it is hard to rebuild, and that the one to two percentage point growth slowdown could deepen if retail redemptions persist.

All eyes are now on July 15, when the company releases its trading update. Management will reveal the latest assets under management, currently $184.9 billion. If that figure has fallen, the stock could face another leg down. If it holds or rises, the insider buying may look prescient. The stakes are enormous: the projected dividend yield already stands at over 6.5%, implying the market is pricing in a much weaker outlook than the board is.

In the end, the battle for Partners Group will be decided by two numbers: gross inflows and net Evergreen outflows. Both will be laid bare next week. The insiders have put their money where their mouth is. Now the data will show whether they were buying a bargain or catching a falling knife.

Ad

Partners Group Stock: Buy or Sell?! New Partners Group Analysis from June 30 delivers the answer:

The latest Partners Group figures speak for themselves: Urgent action needed for Partners Group investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from June 30.

Partners Group: Buy or sell? Read more here...

Tags: Partners Group
Kennethcix

Kennethcix

Related Posts

Take-Two Stock
Analysis

Code in a Box, Cash in the Bank: Take-Two Rides GTA VI’s Pre-Order Tsunami Past the Disc-Only Backlash

June 30, 2026
IperionX Stock
Analysis

IperionX Shares Pop 11% as Texas Capital Joins Bull Camp – But the Bear Case Is Still Priced In

June 30, 2026
XPeng Stock
Analysis

XPeng Juggles VW Alliance and MONA Debut as June Delivery Target Looms Large

June 30, 2026
Next Post
Bloom Energy Stock

Bloom Energy's Self-Generation Thesis Gains Traction as Developers Flee the Grid — But a 128x Earnings Tag Leaves No Room for Error

Coca-Cola Stock

Half-Time Report: Cash Flow Wins the Second Half

FALLBACK Stock

Transporter Shake-Up: Smart Tachographs, Dutch Toll, and EU Work-Time Ruling All Hit in July 2026

Recommended

DVY stock news

Analysts revise projections for FTC Solar post Q4 results Stock downgraded but revenue growth expected

2 years ago
Strategy Stock

Strategy Shares Plunge as Bitcoin Dependency Deepens

8 months ago
Biomedicine plant based (1)

Biotech Breakthrough: Unveiling the Future of Sustainable Textile Innovations

2 years ago
Redcare Pharmacy Stock

Redcare Pharmacy Shares Plunge Following CFO’s Sudden Departure

9 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics XRP
No Result
View All Result

Highlights

Quantum eMotion’s First Revenue Arrives, But the Market Wants More Than Promises

XPeng Juggles VW Alliance and MONA Debut as June Delivery Target Looms Large

Short Sellers Bet Against DeFi Technologies as Nasdaq Deadline Looms — But the Company Has $156 Million Reasons to Fight Back

Transporter Shake-Up: Smart Tachographs, Dutch Toll, and EU Work-Time Ruling All Hit in July 2026

Half-Time Report: Cash Flow Wins the Second Half

Bloom Energy’s Self-Generation Thesis Gains Traction as Developers Flee the Grid — But a 128x Earnings Tag Leaves No Room for Error

Trending

Outlook Therapeutics Stock
Nasdaq

Outlook Therapeutics Clears Nasdaq Hurdle but Faces $39M Debt and FDA Deadline

by Kennethcix
June 30, 2026
0

Outlook Therapeutics has escaped the threat of expulsion from the Nasdaq Capital Market, but the relief is...

Take-Two Stock

Code in a Box, Cash in the Bank: Take-Two Rides GTA VI’s Pre-Order Tsunami Past the Disc-Only Backlash

June 30, 2026
IperionX Stock

IperionX Shares Pop 11% as Texas Capital Joins Bull Camp – But the Bear Case Is Still Priced In

June 30, 2026
Quantum eMotion Stock

Quantum eMotion’s First Revenue Arrives, But the Market Wants More Than Promises

June 30, 2026
XPeng Stock

XPeng Juggles VW Alliance and MONA Debut as June Delivery Target Looms Large

June 30, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Outlook Therapeutics Clears Nasdaq Hurdle but Faces $39M Debt and FDA Deadline
  • Code in a Box, Cash in the Bank: Take-Two Rides GTA VI’s Pre-Order Tsunami Past the Disc-Only Backlash
  • IperionX Shares Pop 11% as Texas Capital Joins Bull Camp – But the Bear Case Is Still Priced In

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com